A detailed history of Jpmorgan Chase & CO transactions in Haemonetics Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 154,723 shares of HAE stock, worth $11.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154,723
Previous 156,819 1.34%
Holding current value
$11.7 Million
Previous $13 Million 4.15%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$72.45 - $91.58 $151,855 - $191,951
-2,096 Reduced 1.34%
154,723 $12.4 Million
Q2 2024

Aug 12, 2024

SELL
$81.24 - $97.37 $2.99 Million - $3.58 Million
-36,746 Reduced 18.98%
156,819 $13 Million
Q1 2024

May 10, 2024

BUY
$71.24 - $85.35 $1.23 Million - $1.47 Million
17,226 Added 9.77%
193,565 $16.5 Million
Q4 2023

Feb 12, 2024

BUY
$80.59 - $92.61 $399,887 - $459,530
4,962 Added 2.9%
176,339 $15.1 Million
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $1.35 Million - $1.52 Million
-16,301 Reduced 8.69%
171,377 $15.4 Million
Q2 2023

Aug 11, 2023

BUY
$80.84 - $89.45 $791,181 - $875,447
9,787 Added 5.5%
187,678 $16 Million
Q1 2023

May 18, 2023

BUY
$72.75 - $90.6 $9.1 Million - $11.3 Million
125,116 Added 237.07%
177,891 $14.7 Million
Q1 2023

May 11, 2023

SELL
$72.75 - $90.6 $7.31 Million - $9.1 Million
-100,430 Reduced 65.55%
52,775 $4.37 Million
Q4 2022

Feb 13, 2023

BUY
$73.85 - $86.14 $498,635 - $581,617
6,752 Added 4.61%
153,205 $12 Million
Q3 2022

Nov 14, 2022

BUY
$63.3 - $78.66 $748,712 - $930,390
11,828 Added 8.79%
146,453 $10.8 Million
Q2 2022

Aug 11, 2022

SELL
$49.27 - $66.08 $22,368 - $30,000
-454 Reduced 0.34%
134,625 $8.77 Million
Q1 2022

May 11, 2022

BUY
$43.77 - $63.22 $1.14 Million - $1.64 Million
26,017 Added 23.86%
135,079 $8.54 Million
Q4 2021

Feb 10, 2022

SELL
$49.55 - $74.59 $202,709 - $305,147
-4,091 Reduced 3.62%
109,062 $5.78 Million
Q3 2021

Nov 12, 2021

BUY
$57.6 - $70.59 $6.52 Million - $7.99 Million
113,153 New
113,153 $7.99 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.87B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.